Sorafenib-Based Drug Delivery Systems: Applications and Perspectives

Sorafenib-Based Drug Delivery Systems: Applications and Perspectives

As a Food and Drug Administration (FDA)-approved molecular-targeted chemotherapeutic drug, sorafenib (SF) can inhibit angiogenesis and tumor cell proliferation, leading to improved patient overall survival of hepatocellular carcinoma (HCC). In addition, SF is an oral multikinase inhibitor as a singl...

Full description

Bibliographic Details
Main Authors: Lingyun Wang, Meihuan Chen, Xueguang Ran, Hao Tang, Derong Cao
Format: Article
Language:English
Published: MDPI AG 2023-06-01
Series:Polymers
Subjects:
sorafenib
multi-kinase inhibitor
nanodelivery systems
hepatocellular carcinoma (HCC)
nano-sized carriers
tumor treatment
Online Access:https://www.mdpi.com/2073-4360/15/12/2638

Internet

https://www.mdpi.com/2073-4360/15/12/2638

Similar Items